Neurology, Vol 48, Issue 6 1521-1525, Copyright © 1997 by American Academy of Neurology

ARTICLES

EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease

OL Lopez, RP Brenner, JT Becker, RF Ulrich, F Boller and ST DeKosky
Department of Neurology, University of Pittsburgh School of Medicine, PA, USA.

We examined whether either psychotic features (e.g., delusions and hallucinations) or EEG abnormalities are associated with more rapid progression of Alzheimer's disease (AD). AD patients with psychosis have exhibited more EEG abnormalities than those without psychosis, and both abnormal EEG and psychosis have been noted to be predictors of functional and cognitive decline in AD. Ninety-five probable AD patients participating in a longitudinal study of dementia had an EEG and a semistructured psychiatric interview at baseline. Using EEG spectral analysis, we classified records as normal/abnormal based on the parasagittal mean frequency. Patients with abnormal EEGs were more functionally (e.g., Blessed Rating Scale for activities of daily living) and cognitively (e.g., Mini-Mental State) impaired than patients with normal EEG. AD patients with psychosis were only more functionally impaired than patients without psychosis. A two-factor analysis showed no interaction between abnormal EEG and psychosis. In addition, using a Cox proportional hazard model adjusted for age and education, the presence of an abnormal EEG or psychotic symptom at study entry was associated with higher risk of reaching severe cognitive and functional impairment during follow-up. Neither abnormal EEG nor the presence of psychosis predicted death. These results indicate that both abnormal EEG and psychosis are independent predictors of disease progression but not of physical survival.

This article has been cited by other articles:

				D. V. Jeste, T. W. Meeks, D. S. Kim, and G. S. Zubenko Research Agenda for DSM-V: Diagnostic Categories and Criteria for Neuropsychiatric Syndromes in Dementia J Geriatr Psychiatry Neurol, September 1, 2006; 19(3): 160 - 171. [Abstract] [PDF]

				N. Scarmeas, J. Brandt, M. Albert, G. Hadjigeorgiou, A. Papadimitriou, B. Dubois, M. Sarazin, D. Devanand, L. Honig, K. Marder, et al. Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease Arch Neurol, October 1, 2005; 62(10): 1601 - 1608. [Abstract] [Full Text] [PDF]

				C. Fischer, R. Bozanovic-Sosic, and M. Norris Review of delusions in dementia American Journal of Alzheimer's Disease and Other Dementias, January 1, 2004; 19(1): 19 - 23. [Abstract] [PDF]

				R. S Wilson, D. W Gilley, D. A Bennett, L. A Beckett, and D. A Evans Hallucinations, delusions, and cognitive decline in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 172 - 177. [Abstract] [Full Text] [PDF]

				O. L. Lopez, S. R. Wisniewski, J. T. Becker, F. Boller, and S. T. DeKosky Psychiatric Medication and Abnormal Behavior as Predictors of Progression in Probable Alzheimer Disease Arch Neurol, October 1, 1999; 56(10): 1266 - 1272. [Abstract] [Full Text] [PDF]

				J. J. Claus, B. W. Ongerboer de Visser, G. J. M. Walstra, A. Hijdra, B. Verbeeten Jr, and W. A. van Gool Quantitative Spectral Electroencephalography in Predicting Survival in Patients With Early Alzheimer Disease Arch Neurol, August 1, 1998; 55(8): 1105 - 1111. [Abstract] [Full Text] [PDF]